---
title: "Melanoma survival by tumour thickness in Norway, 1983–2019"
author: "Raju Rimal"
date: "15 Nov, 2023"
institute: |
  Oslo Centre for Biostatistics and Epidemiology (OCBE)<br>
  Department of Biostatistics, UiO<br>
  <span class="text-green conf" >NOFE-2023, Trondheim</span>
code-overflow: scroll
date-format: "DD MMMM YYYY"
bibliography: References.bib
citations-hover: true
preview-links: true
knitr:
  opts_chunk: 
    collapse: true
    comment: "#>" 
execute: 
  echo: false
  warning: false
format: 
  revealjs:
    slide-number: true
    auto-animate-easing: ease-in-out
    auto-animate-unmatched: false
    auto-animate-duration: 0.5
    navigation-mode: linear
    transition: none
    background-transition: none
    template-partials:
      - title-slide.html
    theme: [default, custom.scss]
    logo: Images/Logos/UiO-Logo.png
    title-slide-attributes:
      data-background-color: "#FCFCFC"
      data-background-image: Images/melo.svg
      data-background-opacity: "0.75"
      data-background-size: auto 80%
      data-background-position: 90% center
editor_options: 
  chunk_output_type: console
nocite: "@*"
---

# Somewhere, something incredible is waiting to be known. {.center .quote visibility="hidden"}

::: {style="text-align:right; border-right: 2px solid #0f0f0f; padding-right: 15px; margin-top: 50px; color: #0f0f0f;"}
Dr. Carl Sagan (1934--1996)
:::

::: {style="text-align:right; border-right: 2px solid gray; padding-right: 15px; font-size: 80%; color: gray"}
American astronomer and science communicator
:::

# Outline {.ai .dark .columns background-image="Images/AI/Steps-Spiral.jpg" background-position="right" background-size="auto 100%" visibility="hidden"}

::: {.column width="50%"}
-   [Background](#background)

-   [Research Objective](#aim)

-   [Case series](#case-series)

-   [Analysis](#analysis)

-   [Summary](#summary)
:::

::: {.column width="50%"}
:::

# Background {#background .huge background-image="Images/Backgrounds/Background.jpg"}

##  {.center background-image="Images/melo.svg" background-position="10% 50%" background-size="auto 80%" background-opacity="0.5"}

::: columns
::: {.column width="40%"}
:::

::: {.column width="60%"}
![](Images/GLOBOCAN.svg){width="100%"}
:::
:::

## Melanoma staging and tumour thickness {.middle}

::: {.columns .grid style="align-items: start; grid-template-columns: 5fr 2fr;"}
::: column
### Tumour thickness (T categories)

![Source: [`https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/tnm-staging`](https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/tnm-staging)](Images/T-Stages.svg){width="100%" fig-align="right"}
:::

::: {.column .fragment .fade-left}
### Clinical stages

::: small
::: {.callout-note appearance="default" icon="false"}
#### Localized

No spread
:::

::: {.callout-note appearance="default" icon="false"}
#### Regional Metastasis

Spread to nearby structure or lymph nodes
:::

::: {.callout-note appearance="default" icon="false"}
#### Distant Metastasis

Spread to distant body parts
:::
:::
:::
:::

```{r}
#| include: false
library(data.table)
library(ggplot2)
library(stringr)
library(purrr)
library(ggh4x)
library(gt)

ggplot2::theme_set(ggthemes::theme_few())
theme_update(panel.grid = element_line(color = "#f0f0f0"))
counts <- readRDS("Data/Counts.Rds")
```

```{=html}
<!--
# Color schemes (uchicago):
#   Default: default_uchicago:
#     #800000 #767676 #FFA319 #8A9045 #155F83 
#     #C16622 #8F3931 #58593F #350E20
#   Dark: dark_uchicago:
#     #800000 #767676 #CC8214 #616530 #0F425C 
#     #9A5324 #642822 #3E3E23 #350E20 
#   Light: light_uchicago:
#     #800000 #D6D6CE #FFB547 #ADB17D #5B8FA8 
#     #D49464 #B1746F #8A8B79 #725663
#   White:
#     #FFFAFA #FCFCFC #FFFDFD #FCFFE0 #F9FCFF 
#     #FFFCFB #FFFAFA #FCFDE5 #FFF8FA
-->
```
# Research Objective {#aim .center .middle}

To examine ***mortality*** and ***survival*** by ***tumour thickness*** overall and in important subgroups such as *sex* and *clinical stage* in a unique nationwide case series over a 35-year period.

# Case series {#case-series .huge background-image="Images/Backgrounds/Case-Series.jpg"}

## Data from Cancer Registry of Norway {.middle}

![](Images/Data-Timeline.svg){width="100%"}

::: {.columns .grid style="grid-template-columns: 1fr max-content; margin-top:0; align-items: flex-start;"}
::: {style="font-size: 85%;"}
- All histologically verified first primary invasive melanoma
- Aged between 15 and 90
:::
::: column
![](Images/Logos/CRN-Logo.svg){fig-align="right" width="100%"}
:::
:::


## Basic characteristics of data

```{r}
table_data <- data.table(
  label = c(
    "Frequency", "Percentage", 
    "Age at diagnosis", 
    "Tumour thickness"
  ),
  Men = c("21,864", "48.7", "64 (52-74)", "1.1 (0.7-2.5)"),
  Women = c("23,053", "51.3", "60 (46-73)", "1 (0.6-1.9)")
)
```

::: {.columns .grid style="grid-template-columns: 2fr 1fr; align-items: flex-start;"}
::: {.column .grid style="grid-template-rows: auto 1fr 1fr;"}

### Age and Thickness


```{r}
gt::gt(
  table_data,
  rowname_col = "label"
) %>% gt::tab_stub_indent(
  rows = matches("Median"),
  indent = 5
) %>% gt::tab_style(
  style = gt::cell_text(weight = "bold"),
  locations = list(
    gt::cells_column_labels(),
    gt::cells_stub(
      rows = matches("^Age|^Tumour")
    )
  )
) %>% gt::opt_table_font(font = "IBM Plex Mono") %>% 
  gt::tab_footnote(
    "Median (IQR)",
    locations = gt::cells_stub(rows = matches("^Age|^Tumour"))
  ) %>% 
  gt::tab_options(
    table.width = "100%",
    container.width = "100%",
    table.font.size = "60%"
  )
```

::: {.callout-quote appearance="minimal"}
Men were diagnosed at older age and more advanced stage.
:::
:::

::: {.column}
### Clinical stage

::: {.small}
::: {.callout-note appearance="minimal"}
78% cases were localized melanoma 
:::
::: {.callout-note appearance="minimal"}
50% of localized were in T1 category
:::
::: {.callout-note appearance="minimal"}
T3/T4 were more common in cases with regional and distant metastases
:::
::: {.callout-note appearance="minimal"}
70% distant metastasis cases had unspecified thickness
:::
:::
:::
:::

::: notes
**Missing in distant cases:** It is quite common that thickness is missing for the most serios cases.

(Thickness is the most important prognosis factor in the cases with localized mealnoma)
:::

# Analysis & Results {#analysis .huge background-image="Images/Backgrounds/Analysis.jpg"}

## Net survival {.huge .center background-color="#FCFDE5"}

**Net survival compares the survival of people with melanoma with those who don't** over a certain period of time.

::: {.columns .grid style="grid-template-columns: auto auto;"}
::: column
::: {.callout-note appearance="simple" icon="false"}
Computed as the proportion of observed survivors to the expected survivors in a comparable cohort of patients.
:::
:::

::: column
::: {.callout-note appearance="simple" icon="false"}
Estimated with Pohar-Perme method and age-adjusted using International International Cancer Survival Standards (ICSS2) weights.
:::
:::
:::

## Net survival

::: {.columns .small .grid style="grid-template-columns: 1fr 65%; align-content:baseline; align-items:flex-end;"}
::: column
### By sex and T category

::: {.callout-note appearance="simple" icon="false"}
More than 10% decrease in net survival with one step increase in T category
:::

::: {.callout-note appearance="simple" icon="false"}
Lower net survival in men than women
:::
:::

::: column
![](plots/net-surv-5.svg){width="100%"}
:::
:::

## Net survival

::: {.columns .small .grid style="grid-template-columns: 1fr 65%; align-content:baseline; align-items:flex-end;"}
::: column
### Conditional net survival

::: {.callout-note appearance="simple" icon="false"}
5-year net survival becomes more similar in all T categories after surviving for a certain number of years.
:::

::: {.callout-note appearance="simple" icon="false"}
**For example**, patients diagnosed with T2 and T3 melanoma have quite similar 5-year net survival after surviving 10 years.
:::
:::

::: column
![](plots/condsurv-crn5.svg){width="100%"}
:::
:::

## Cumulative mortality {.huge .center background-color="#FCFDE5"}

### (Cumulative incidence of death) {style="color:#3d3d3d;padding-bottom: 2em;"}

The cumulative incidence of death up to a given time is the probability of an individual dying by that time.

## Localized

![
► In T1, more people die from other causes than melanoma.
](plots/cuminc-local.svg){width="100%"}


## Regional metastasis


![
► More people die from melanoma than other causes in all T categories.
](plots/cuminc-regional.svg){width="100%"}


## Distant metastasis

![
► Few cases of thin melanoma, not possible with long follow-up.<br>
► Cases with unspecified tumour thickness had mortality similar to T3/T4 melanoma.
](plots/cuminc-distant.svg){width="100%"}

## Is this the effect of treatment? {.smaller .middle}

::: {.columns .grid style="grid-template-columns: 1fr 2fr; align-items: flex-end;"}
::: column
**Melanoma with distant metastasis**

::: {.callout-note appearance="simple" icon="false"}
Around year 2014, immunotherapy was introduced in Norway for stage IV melanoma.
:::

::: {.callout-tip appearance="simple" icon="false"}
Improved survival was observed in 2014--2019 compared to 2008--2013.
:::
:::

::: column
![](plots/cuminc-trt.svg){width="100%"}
:::
:::

# Summary {#summary .smaller background-image="Images/Mountain-from-plane.jpg" background-position="right" background-size="auto 100%"}

::: {.columns .grid style="grid-template-columns: 1fr 1fr; align-items: end;"}
::: {.column .grid style="grid-template-rows: rep(auto, 5)"}
::: {.fragment .semi-fade-out fragment-index="1"}
- Men had worse net survival than women in all T categories
:::

::: {.fragment .fade-in-then-semi-out fragment-index="1"}
- With every increase in T category, net survival decreased by more than 10% in both sexes.
:::

::: {.fragment .fade-in-then-semi-out}
- After surviving a certain number of years, thickness was less relevant
:::

::: {.fragment .fade-in-then-semi-out}
- Improved survival in Stage-IV melanoma after introduction of immunotherapy.
:::
:::

::: column
:::
:::

<!-- #  {visibility="hidden"} -->

##  {#logo-profile .center .smaller}

::: columns
::: {.column width="30%"}
### Collaborators

::: collab-logo
![](Images/Logos/UiO-Logo.png){#uio width="100%"} ![](Images/Logos/CRN-Logo.svg){#crn width="100%"} ![](Images/Logos/QIMR-Logo.png){#qimr width="100%"} ![](Images/Logos/IARC-Logo.png){#iarc width="100%"} ![](Images/Logos/OUS-Logo.png){#ous width="100%"}

::: {#funding}
**Funded by:** ![](Images/Logos/RNF-Logo.svg){#rnf width="100%"}
:::
:::
:::

::: {.column width="70%"}
### Coauthors

::: profile-container
```{r}
#| results: asis
imgs <- dir("Images/Profile", pattern = "^\\d.*profile.*\\.png", full.names = TRUE)
names(imgs) <- gsub(".*\\/\\d{2}-profile-(.*)\\.png", "\\1", imgs) %>% 
    stringr::str_replace_all("-", " ") %>% 
    stringr::str_to_title()
iwalk(imgs, function(img, name) {
  glue::glue(
    '::: {{.profile-card}}',
    '![]({img}){{width="100%"}}',
    '<p>{name}</p>',
    ':::',
    .sep = "\n"
  ) %>% print()
})
```
:::
:::
:::

# Extra slides {#extra .huge background-image="Images/Backgrounds/Extra-Slides.jpg"}

## Basic characteristics of data

```{r}
tbl <- readRDS(here::here("Data/Count-1.Rds"))
tbl_df <- abind::abind(
  count = tbl %>% addmargins(),
  overall = proportions(tbl) %>% 
    addmargins() %>% 
    apply(1:2, scales::percent, 0.1),
  bycstage = proportions(tbl, 1) %>% 
    addmargins() %>% 
    apply(1:2, scales::percent, 0.1),
  bytstage = proportions(tbl, 2) %>% 
    addmargins() %>% 
    apply(1:2, scales::percent, 0.1), 
  along = 3, 
  new.names = c(
    "frequency",
    "% overall",
    "% within Clinical stage",
    "% within T category"
  )) %>%
  aperm(c(3, 2, 1)) %>%
  purrr::array_tree(3) %>%
  purrr::map(as.data.table, keep.rownames = "Measure") %>%
  rbindlist(idcol = "ClinicalStage") %>%
  .[ClinicalStage != "Sum"] %>%
  .[ClinicalStage == "Sum", Measure := "Sum"] %>%
  .[grepl("within T category", Measure), Sum := NA_character_] %>%
  .[, Measure := purrr::map2_chr(ClinicalStage, Measure, function(x, y) {
    if (!grepl("clinical stage", y)) {
      return(y)
    }
    gsub("Clinical stage", gsub(" metastasis", "", x), y)
  })]

get_tbl <- function(tbl_df, stage = NULL) {
  col_names <- names(tbl_df)[-c(1:2, ncol(tbl_df))]
  col_abv <- gsub("(^..).*", "\\1", col_names)
  footnote <- gsub("T. \\((.*)\\)", "\\1", paste(col_abv, col_names, sep = ": ")) %>% 
    paste(collapse = ", ")
  
  tbl_df <- setnames(copy(tbl_df), col_names, col_abv)
  if (!is.null(stage)) {
    tbl_df <- tbl_df[grepl(stage, ClinicalStage)]
  }
  gt::gt(tbl_df, rowname_col = "Measure", groupname_col = "ClinicalStage") %>%
  gt::opt_table_font(font = "monospace") %>%
  gt::sub_missing(missing_text = "") %>%
  gt::tab_stub_indent(
    rows = gt::matches("Overall|Within"),
    indent = 3
  ) %>%
  gt::tab_options(
    table.width = "100%",
    container.width = "100%",
    data_row.padding = "1px",
    row_group.padding = "5px",
    row_group.font.weight = "bold",
    column_labels.font.weight = "bold",
    table.font.size = "50%"
  ) %>%
  gt::tab_source_note(
    source_note = footnote
  )
}
```

### Localized

```{r}
get_tbl(tbl_df, "Local") %>% gt::tab_style(
  style = list(
    gt::cell_fill(color = "firebrick", alpha = 0.15),
    gt::cell_text(weight = "bold", color = "firebrick")
  ),
  locations = list(
    gt::cells_body(
      columns = gt::starts_with("T1"),
      rows = ClinicalStage == "Local" & grepl("overall|Local", Measure)
    ),
    gt::cells_body(
      columns = gt::starts_with("Sum"),
      rows = ClinicalStage == "Local" & grepl("overall", Measure)
    )
  )
)
```

::: {.callout-note appearance="minimal"}
-   More than 78% of cases are localized melanoma out of which almost 40% were in T1 category.
-   Out of all localized melanoma almost 50% cases had thinner tumour upto 1mm.
:::

## Basic characteristics of data

### Regional metastasis

```{r}
get_tbl(tbl_df, "Regional") %>% gt::tab_style(
  style = list(
    gt::cell_fill(color = "firebrick", alpha = 0.15),
    gt::cell_text(weight = "bold", color = "firebrick")
  ),
  locations = list(
    gt::cells_body(
      columns = gt::matches("T3|T4"), 
      rows = grepl("Regional", ClinicalStage) & grepl("Regional", Measure)
    )
  )
)
```

::: {.callout-note appearance="minimal"}
Thicker cases (T3 and T4 categories) were common in melanoma with regional metastasis
:::

## Basic characteristics of data

### Distant metastasis

```{r}
get_tbl(tbl_df, "Distant") %>% gt::tab_style(
  style = list(
    gt::cell_fill(color = "firebrick", alpha = 0.15),
    gt::cell_text(weight = "bold", color = "firebrick")
  ),
  locations = list(
    gt::cells_body(
      columns = gt::matches("Un"), 
      rows = grepl("Distant", ClinicalStage) & 
        grepl("Distant", Measure)
    ),
    gt::cells_body(
      columns = gt::matches("Un|Sum"), 
      rows = grepl("Unsp", ClinicalStage) & 
        grepl("overall", Measure)
    )
  )
)
```

::: {.callout-note appearance="minimal"}
-   Almost 70% of the melanoma cases with distant metastasis had thickness unspecified.
-   Around 13% of the cases had unspecified clinical stage and 3% had both clinical stage and thickness missing.
:::

## Net survival {auto-animate="true" auto-animate-duration="0.25"}

::: {.columns .small .grid style="grid-template-columns: 1fr 65%; align-content:baseline; align-items:flex-end;"}
::: column
### By Clinical stage

::: {.callout-note appearance="simple" icon="false"}
-   Patients with thin (T1) localized melanoma have similar survival as general population.
:::
:::

::: column
![](plots/Table-1a-Plot-5v.svg){width="100%"}
:::
:::

## Net survival {auto-animate="true" auto-animate-duration="0.25"}

::: {.columns .small .grid style="grid-template-columns: 1fr 65%; align-content:baseline; align-items:flex-end;"}
::: column
### By Clinical stage

::: {.callout-note appearance="simple" icon="false"}
-   Patients with thin (T1) localized melanoma have similar survival as general population.
:::

::: {.callout-note appearance="simple" icon="false"}
-   Distant metastasis cases have low net survival regardless of tumour thickness.
:::
:::

::: column
![](plots/Table-1a-Plot-5v-ann.svg){width="100%"}
:::
:::

##  {background-image="Images/Thank-You.png" background-size="auto 90%"}

## References {.smaller}

::: {#refs}
:::
